Targeted delivery of cancer-specific multimodal contrast agents for intraoperative detection of tumor boundaries and therapeutic margins

Ronald X. Xu; Jeff S. Xu; Jiwei Huang; Michael F. Tweedle; Carl Schmidt; Stephen P. Povoski; Edward W. Martin

doi:10.1117/12.848299

23 February 2010 Targeted delivery of cancer-specific multimodal contrast agents for intraoperative detection of tumor boundaries and therapeutic margins

Ronald X. Xu, Jeff S. Xu, Jiwei Huang, Michael F. Tweedle, Carl Schmidt, Stephen P. Povoski, Edward W. Martin

Author Affiliations +

Proceedings Volume 7556, Design and Quality for Biomedical Technologies III; 75560T (2010) https://doi.org/10.1117/12.848299
Event: SPIE BiOS, 2010, San Francisco, California, United States

Abstract

Background: Accurate assessment of tumor boundaries and intraoperative detection of therapeutic margins are important oncologic principles for minimal recurrence rates and improved long-term outcomes. However, many existing cancer imaging tools are based on preoperative image acquisition and do not provide real-time intraoperative information that supports critical decision-making in the operating room. Method: Poly lactic-co-glycolic acid (PLGA) microbubbles (MBs) and nanobubbles (NBs) were synthesized by a modified double emulsion method. The MB and NB surfaces were conjugated with CC49 antibody to target TAG-72 antigen, a human glycoprotein complex expressed in many epithelial-derived cancers. Multiple imaging agents were encapsulated in MBs and NBs for multimodal imaging. Both one-step and multi-step cancer targeting strategies were explored. Active MBs/NBs were also fabricated for therapeutic margin assessment in cancer ablation therapies. Results: The multimodal contrast agents and the cancer-targeting strategies were tested on tissue simulating phantoms, LS174 colon cancer cell cultures, and cancer xenograft nude mice. Concurrent multimodal imaging was demonstrated using fluorescence and ultrasound imaging modalities. Technical feasibility of using active MBs and portable imaging tools such as ultrasound for intraoperative therapeutic margin assessment was demonstrated in a biological tissue model. Conclusion: The cancer-specific multimodal contrast agents described in this paper have the potential for intraoperative detection of tumor boundaries and therapeutic margins.

Citation Download Citation

Ronald X. Xu, Ronald X. Xu, Jeff S. Xu, Jeff S. Xu, Jiwei Huang, Jiwei Huang, Michael F. Tweedle, Michael F. Tweedle, Carl Schmidt, Carl Schmidt, Stephen P. Povoski, Stephen P. Povoski, Edward W. Martin, Edward W. Martin, "Targeted delivery of cancer-specific multimodal contrast agents for intraoperative detection of tumor boundaries and therapeutic margins", Proc. SPIE 7556, Design and Quality for Biomedical Technologies III, 75560T (23 February 2010); doi: 10.1117/12.848299; https://doi.org/10.1117/12.848299

ACCESS THE FULL ARTICLE

PERSONAL SIGN IN
Full access may be available with your subscription

Email or Username Forgot your username?

Password Forgot your password?

Show

Remember Email/Username on this computer

Remember Password

No SPIE account? Create an account
or Institutional Sign In via Shibboleth

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $14.40

Non-members: $18.00 ADD TO CART

Show All Keywords

Keywords/Phrases

Search In:

Publication Years